docetaxelTJ-M2010-5metastatic NSCLCplatinum therapy
…d FDA approval for concurrent use with PD-1/PD-L1 inhibitors or docetaxel in metastatic NSCLC progressing after platinum therapy. The cur…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…d FDA approval for concurrent use with PD-1/PD-L1 inhibitors or docetaxel in metastatic NSCLC progressing after platinum therapy. The cur…
…suggesting that DC inclusion dampens the macrophage response to bemcentinib.9 Separation of macrophages by A375 state was further reflected…
…erapy will be included and randomised 1:1 to receive either (1) docetaxel (or paclitaxel), carboplatin, trastuzumab (H) and pertuzumab (P…